Back

Metformin mitigates insulin signaling variations induced by COVID-19 vaccine boosters in type 2 diabetes

2024-01-02 endocrinology Title + abstract only
View on medRxiv
Show abstract

Diabetes is associated with an increased risk of Coronavirus disease 2019 (COVID-19) vulnerability and mortality. COVID-19 vaccines significantly reduce the risks of serious COVID-19 outcomes, but the impact of COVID-19 vaccines including their effectiveness and adverse effects in patients with diabetes are not well known yet. Here, we showed that 61.1% patients with type 2 diabetes, but not healthy controls, exhibited aggravated insulin resistance towards the booster shots of the COVID-19 vacci...

Predicted journal destinations